BLBD vs CMPR
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
BLBD exhibits strong financial health with a Piotroski F-Score of 8/9, indicating robust operational and balance sheet strength. The company is growing rapidly, with 16.9% YoY revenue growth and 51.8% earnings growth, supported by improving margins and high returns on equity and assets. Despite a premium valuation relative to the Graham Number ($26.31) and elevated Price/Book ratio, the stock trades below the growth-based intrinsic value estimate of $113.28 and has a strong analyst consensus. However, recent insider selling activity presents a notable counter-signal to the otherwise positive fundamentals.
CMPR shows bearish fundamentals based on deterministic rules. Financial strength is stable (F-Score 4/9). Concerns include weak profitability or high valuation.
Compare Another Pair
Related Comparisons
BLBD vs CMPR: Head-to-Head Comparison
This page compares Blue Bird Corporation (BLBD) and Cimpress plc (CMPR) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.